Human papillomavirus vaccine initiation and awareness u.s. young men in the 2010: National health interview survey

American Journal of Preventive Medicine

Volumn 44, Issue 4, 2013, Pages 330-338

  Lu, Peng Jun ^a   Williams, Walter W ^b   Li, Jun ^b   Dorell, Christina ^b   Yankey, David ^a   Kepka, Deanna ^d   Dunne, Eileen F ^c  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADULT; ARTICLE; AWARENESS; HEALTH INSURANCE; HEALTH SURVEY; HIGH RISK BEHAVIOR; HUMAN; MALE; PREVENTIVE HEALTH SERVICE; SEXUALLY TRANSMITTED DISEASE; VACCINATION; VIRUS INFECTION; WART VIRUS; YOUNG ADULT; ADOLESCENT; ATTITUDE TO HEALTH; DRUG APPROVAL; FOOD AND DRUG ADMINISTRATION; PAPILLOMAVIRUS INFECTION; UNITED STATES;

ADOLESCENT; ADULT; DRUG APPROVAL; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SURVEYS; HUMANS; IMMUNIZATION PROGRAMS; MALE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; YOUNG ADULT;

EID: 84884198749     PISSN: 07493797     EISSN: 18732607     Source Type: Journal    
DOI: 10.1016/j.amepre.2012.11.027     Document Type: Article

References (55)

1. CDC. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007;56(RR-2):1-24
2. Schiffman M, Kjaer SK. Natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr 2003;31: 14-9
3. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 1997;102:3-8
4. CDC. Recommendations on the use of quadrivalent human papillomavirus vaccine in males-Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 2011;60(50): 1705-8
5. Joseph DA, Miller JW, Wu X, et al. Understanding the burden of human papillomavirus-associated anal cancers in the U.S. Cancer 2008;113(10S):2892-900
6. Gillison ML, Chaturvedi AK, Lowy DR. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer 2008;113(10S):3036-46
7. Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the U.S. J Clin Oncol 2011;29:4294-301
8. Saraiya M. Burden of HPV-associated cancers in the U.S. Presentation before the Advisory Committee on Immunization Practices (ACIP), February 24, 2011. Atlanta GA: DHHS, CDC, 2011. www.cdc.gov/vaccines/recs/acip/downloads/mtg- slides-feb11/11-2-hpv-rela-cancer. pdf.
9. Hu D, Goldie S. The economic burden of noncervical human papillomavirus disease in the U.S. Am J Obstet Gynecol 2008;198:500-7
10. Hoy T, Singhal PK, Willey VJ, Insinga RP. Assessing incidence and economic burden of genital warts with data from a U.S. commercially insured population. Curr Med Res Opin 2009;25:2343-51
11. CDC. The Advisory Committee on Immunization Practices (ACIP): summary report, October 27-28, 2010, Atlanta GA. www.cdc.gov/vaccines/recs/acip/ downloads/min-archive/min-oct10.pdf.
12. CDC. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP).MMWRMorb Mortal Wkly Rep 2010;59(20):630-2
13. Gutierrez B Jr, Leung A, Jones KT, et al. Acceptability of the human papillomavirus vaccine among urban adolescent males. Am J Mens Health 2013;7(1):27-36
14. Reiter PL, McRee AL, Kadis JA, Brewer NT. HPV vaccine and adolescent males. Vaccine 2011;29(34):5595-602
15. CDC. National Health Interview Survey. ftp://ftp.cdc.gov/pub/Health- Statistics/NCHS/Dataset-Documentation/NHIS/2010/srvydesc. pdf.
16. Jain N, Euler GL, Shefer A, Lu P, Yankey D, Markowitz L. Human papillomavirus (HPV) awareness and vaccination initiation among women in the U.S., National Immunization Survey-Adult 2007. Prev Med 2009;48(5):426-31
17. Medeiros R, Ramada D. Knowledge differences between male and female university students about human papillomavirus (HPV) and cervical cancer: implications for health strategies and vaccination. Vaccine 2010 16;29(2):153-60
18. Marek E, Dergez T, Rebek-Nagy G, et al. Adolescents' awareness of HPV infections and attitudes towards HPV vaccination 3 years following the introduction of the HPV vaccine in Hungary. Vaccine 2011;29(47):8591-8
19. Pitching protection, to both mothers and daughters. www.nytimes. com/2007/02/18/arts/television/18dede.html?-r-2
20. Oh JK, Lim MK, Yun EH, Lee EH, Shin HR. Awareness of and attitude towards human papillomavirus infection and vaccination for cervical cancer prevention among adult males and females in Korea: a nationwide interview survey. Vaccine 2010;28:1854-60
21. Tiro JA, Meissner HI, Kobrin S, Chollette V. What do women in the U.S. know about human papillomavirus and cervical cancer? Cancer Epidemiol 2007;16(2):288-94
22. CDC. Education & training: 2012 epidemiology & prevention of vaccine-preventable diseases. www.cdc.gov/vaccines/ed/epivac/default. htm.
23. CDC. Education & training: vaccine-preventable diseases: HPV vaccination. www.cdc.gov/vaccines/vpd-vac/hpv/default.htm .
24. HPV vaccine now recommended for boys and young men. www. medscape.com/viewarticle/759820
25. HPV4 vaccine information statement. www.cdc.gov/vaccines/pubs/vis/ downloads/vis-hpv-gardasil.pdf.
26. HPV vaccines offer disease protection pre-teens can grow into-now for girls and boys. www.cdc.gov/media/subtopic/matte/pdf/2010/hpvvaccine-preteens. pdf.
27. Callahan ST, Cooper WO. Gender and uninsurance among young adults in the U.S. Pediatrics 2004;113(2):291-7
28. Sherris J, Friedman A, Wittet S, Davies P, Steben M, Saraiya M. Chapter 25: Education, training, and communication for HPV vaccines. Vaccine 2006;24(S3):S210-S218
29. Cui Y, Baldwin SB, Wiley DJ, Fielding JE. Human papillomavirus vaccine among adult women: disparities in awareness and acceptance. Am J Prev Med 2010;39(6):559-63
30. Niccolai LM, Mehta NR, Hadler JL. Racial/ethnic and poverty disparities in human papillomavirus vaccination completion.AmJ Prev Med 2011;41(4):428-33
31. Liddon NC, Leichliter JS, Markowitz LE. Human papillomavirus vaccine and sexual behavior among adolescent and young women. Am J Prev Med 2012;42(1):44-52
32. Reiter PL, Brewer NT, Gottlieb SL, McRee AL, Smith JS. Parents' health beliefs andHPVvaccination of their adolescent daughters. Soc Sci Med 2009;69(3):475-80
33. Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory informed, systematic review. Prev Med 2007;45(2-3):107-14
34. Hughes J, Cates JR, Liddon N, Smith JS, Gottlieb SL, Brewer NT. Disparities in how parents are learning about the human papillomavirus vaccine. Cancer Epidemiol Biomarkers Prev 2009;18(2):363-72
35. Briss PA, Rodewald LE, Hinman AR, et al. Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults. The Task Force on Community Preventive Services. Am J Prev Med 2000;18(1S):97-140
36. Tierney CD, Yusuf H, McMahon SR, et al. Adoption of reminder and recall messages for immunizations by pediatricians and public health clinics. Pediatrics 2003;112(5):1076-82
37. Anhang Price R, Tiro JA, Saraiya M, Meissner H, Breen N. Use of human papillomavirus vaccines among young adult women in the U.S.: an analysis of the 2008 National Health Interview Survey. Cancer 2011;117(24):5560-8
38. Miller BL, Kretsinger K, Euler GL, Lu PJ, Ahmed F. Barriers to early uptake of tetanus, diphtheria and acellular pertussis vaccine (Tdap) among adults-U.S., 2005-2007. Vaccine 2011;29(22):3850-6
39. Lu PJ, Euler GL, Hennessey KA, Weinbaum CM. Hepatitis A vaccination coverage among adults aged 18-49 years in the U.S. Vaccine 2009;27(9):1301-5
40. Bednarczyk RA, Birkhead GS, Morse DL, Doleyres H, McNutt LA. Human papillomavirus vaccine uptake and barriers: association with perceived risk, actual risk and race/ethnicity among female students at a New York State university, 2010. Vaccine 2011;29(17):3138-43
41. Taylor LD, Hariri S, Sternberg M, Dunne EF, Markowitz LE. Human papillomavirus vaccine coverage in the U.S., National Health and Nutrition Examination Survey, 2007-2008. Prev Med 2011;52(5): 398-400
42. Stokley S, Cohn A, Dorell C, et al. Adolescent vaccination-coverage levels in the U.S.: 2006-2009. Pediatrics 2011;128(6):1078-86
43. Egede LE, Zheng D. Racial/ethnic differences in adult vaccination among individuals with diabetes. Am J Public Health 2003;93(2): 324-9
44. Smith PJ, Stevenson J, Chu SY. Associations between childhood vaccination coverage, insurance type, and breaks in health insurance coverage. Pediatrics 2006;117(6):1972-8
45. Kempe A, Beaty B, Englund BP, Roark RJ, Hester N, Steiner JF. Quality of care and use of the medical home in a state-funded capitated primary care plan for low-income children. Pediatrics 2000;105(5):1020-8
46. Holl JL, Szilagyi PG, Rodewald LE, et al. Evaluation of New York State's Child Health Plus: access, utilization, quality of health care, and health status. Pediatrics 2000;105(3S E):711-8
47. Dombkowski KJ, Lantz PM, Freed GL. Role of health insurance and a usual source of medical care in age-appropriate vaccination. Am J Public Health 2004;94(6):960-6
48. Merck Vaccine Patient Assistance Program. www.merck.com/merckhelps/ vaccines/qualify.html.
49. CDC. Immunization Grant Program (Section 317). www.cdc.gov/NCIRD/ progbriefs/downloads/grant-317.pdf.
50. CDC. Adult vaccination coverage, U.S., 2010. MMWR Morb Mortal Wkly Rep 2012;61(4):66-72
51. The Affordable Care Act. www.healthcare.gov/law/full/index.html .
52. Donald RM, Baken L, Nelson A, Nichol KL. Validation of self-report of influenza and pneumococcal vaccination status in elderly outpatients. Am J Prev Med 1999;16(3):173-7
53. Shenson D, Dimartino D, Bolen J, Campbell M, Lu PJ, Singleton JA. Validation of self-reported pneumococcal vaccination in behavioral risk factor surveillance surveys: experience from the sickness prevention achieved through regional collaboration (SPARC) program. Vaccine 2005;23(8):1015-20
54. Dorell CG, Jain N, Yankey D. Validity of parent-reported vaccination status for adolescents aged 13-17 years: National Immunization Survey-Teen, 2008. Public Health Rep 2011;126(S2):60-9
55. Poland GA, Shefer AM, McCauley M, et al. Standards for adult immunization practice. Am J Prev Med 2003;25(2):144-50.